Focused Wealth Management Inc Grows Holdings in UnitedHealth Group Incorporated $UNH

Focused Wealth Management Inc lifted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 18.3% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 8,174 shares of the healthcare conglomerate’s stock after acquiring an additional 1,263 shares during the quarter. Focused Wealth Management Inc’s holdings in UnitedHealth Group were worth $2,212,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. Centennial Wealth Advisory LLC purchased a new stake in shares of UnitedHealth Group in the first quarter valued at approximately $208,000. Keudell Morrison Wealth Management increased its holdings in UnitedHealth Group by 17.9% in the 1st quarter. Keudell Morrison Wealth Management now owns 2,844 shares of the healthcare conglomerate’s stock worth $770,000 after acquiring an additional 432 shares in the last quarter. EdgeRock Capital LLC lifted its holdings in UnitedHealth Group by 13.0% during the first quarter. EdgeRock Capital LLC now owns 3,092 shares of the healthcare conglomerate’s stock valued at $833,000 after purchasing an additional 355 shares in the last quarter. Cidel Asset Management Inc. raised its position in shares of UnitedHealth Group by 38.8% during the 1st quarter. Cidel Asset Management Inc. now owns 12,757 shares of the healthcare conglomerate’s stock worth $3,452,000 after purchasing an additional 3,565 shares during the last quarter. Finally, Richards Merrill & Peterson Inc. raised its holdings in shares of UnitedHealth Group by 5.3% during the first quarter. Richards Merrill & Peterson Inc. now owns 2,647 shares of the healthcare conglomerate’s stock valued at $716,000 after acquiring an additional 134 shares during the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several brokerages recently commented on UNH. Mizuho boosted their price target on UnitedHealth Group from $440.00 to $460.00 and gave the stock an “outperform” rating in a research report on Monday, June 8th. TD Cowen reaffirmed a “buy” rating on shares of UnitedHealth Group in a report on Monday. UBS Group raised their price target on shares of UnitedHealth Group from $410.00 to $460.00 and gave the stock a “buy” rating in a research note on Friday, May 22nd. HSBC raised shares of UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $300.00 price objective for the company in a research note on Tuesday, April 7th. Finally, Erste Group Bank upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Monday, April 27th. One research analyst has rated the stock with a Strong Buy rating, twenty-one have given a Buy rating, four have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $409.75.

UnitedHealth Group Price Performance

UnitedHealth Group stock opened at $409.32 on Wednesday. The company has a current ratio of 0.80, a quick ratio of 0.80 and a debt-to-equity ratio of 0.69. The stock has a market cap of $371.72 billion, a P/E ratio of 30.92, a PEG ratio of 1.64 and a beta of 0.64. The company has a 50-day moving average price of $377.77 and a 200 day moving average price of $330.66. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $415.98.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, April 21st. The healthcare conglomerate reported $7.23 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.76 by $0.47. UnitedHealth Group had a net margin of 2.68% and a return on equity of 14.65%. The business had revenue of $111.65 billion during the quarter, compared to the consensus estimate of $109.84 billion. During the same quarter last year, the firm earned $7.20 EPS. The business’s revenue was up 2.0% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. Sell-side analysts anticipate that UnitedHealth Group Incorporated will post 18.32 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 23rd. Investors of record on Monday, June 15th were given a dividend of $2.32 per share. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.3%. The ex-dividend date of this dividend was Monday, June 15th. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $2.21. UnitedHealth Group’s dividend payout ratio is 70.09%.

Insider Buying and Selling

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 800 shares of the stock in a transaction dated Thursday, April 23rd. The shares were sold at an average price of $355.00, for a total transaction of $284,000.00. Following the completion of the transaction, the chief executive officer owned 17,805 shares of the company’s stock, valued at $6,320,775. This trade represents a 4.30% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 0.28% of the stock is owned by insiders.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.